CD200 R1

CD200 R1 Informations sur la molécule

Nom anglaisCell surface glycoprotein CD200 receptor 1Nombre de médicaments commercialisés0
Nombre de médicaments cliniques4Alias de la cibleCell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisCell surface glycoprotein CD200 receptor 1
Alias de la cibleCell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques4
Phase de R&D la plus avancéePhase 2 Clinical

CD200 R1 Liste de produits

  • Attribut

    Protein (2)

  • Bibliothèque de produits

    En ligne (2)

  • Espèces

    Human (2)

  • Étiquette

    Fc Tag & Avi Tag (1)His Tag (1)

  • Marqueur

    Biotin-labeled (1)Unconjugated (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
Human
HEK293
Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)
Ajouter au panier
Human
HEK293
Biotinylated Human CD200 R1 / CRTR2 Protein, Fc,Avitag™
Ajouter au panier
Quantité totale2
  • 1

CD200 R1Contexte de la molécule

Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene. This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

CD200 R1Alias de la molécule

CD200R,CRTR2,MOX2R,OX2R

Coopération sous licence

Nom du projetType de médicamentDomain thérapeutiqueIndicationPhaseZone de droits
High selective OX1R/OX2R dual inhibitor treating insomniaSmall moleculeNeurological diseaseInsomniaPhase IGlobal

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme IncCarcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
GS-5305GS-5305Phase 1 ClinicalGilead Sciences LdaInflammation
Details
DS-234DS-234; ARQ-234Phase 1 ClinicalDucentis BioTherapeutics LtdDermatitis, Atopic; Eczema
Details
UcenprubartLY-3454738Phase 1 ClinicalEli Lilly And CompanyChronic Urticaria; Dermatitis, Atopic
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques